Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NEI

Surgical Tool For Ocular Tissue Transplantation

  • Read more about Surgical Tool For Ocular Tissue Transplantation
US Application 61/845,598
Filed on 2013-07-12

Methods And Compositions For Treating Genetically Linked Diseases Of The Eye

  • Read more about Methods And Compositions For Treating Genetically Linked Diseases Of The Eye
US Application 61/815,636
Filed on 2013-04-24

Methods And Compositions For Treating Genetically Linked Diseases Of The Eye

  • Read more about Methods And Compositions For Treating Genetically Linked Diseases Of The Eye
US Application 61/765,654
Filed on 2013-02-15

Methods For Using Lubiprostone To Absorb Fluid From The Subretinal Space

  • Read more about Methods For Using Lubiprostone To Absorb Fluid From The Subretinal Space
US Application 61/777,073
Filed on 2013-03-12

METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM (IPS) CELLS

  • Read more about METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM (IPS) CELLS
US Application 61/759,988
Filed on 2013-02-01

METHOD OF REDUCING ADVERSE EFFECTS IN A CANCER PATIENT DURING TREATMENT WITH A MEK INHIBITOR

  • Read more about METHOD OF REDUCING ADVERSE EFFECTS IN A CANCER PATIENT DURING TREATMENT WITH A MEK INHIBITOR
US Application 61/721,810
Filed on 2012-11-02

Methods of Producing And Using Regulatory B Cells

  • Read more about Methods of Producing And Using Regulatory B Cells
US Application 61/637,915
Filed on 2012-04-25

Methods of Diagnosing and Treating Age-Related Macular Degeneration

  • Read more about Methods of Diagnosing and Treating Age-Related Macular Degeneration
US Application 61/435,989
Filed on 2011-01-25

Dual-function Needle

  • Read more about Dual-function Needle
US Application 61/533,908
Filed on 2011-09-13

Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice

  • Read more about Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice
US Application 61/310,043
Filed on 2010-03-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • …
  • Next page ››
  • Last page Last »
Subscribe to NEI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health